Table 1.
Antibiotic susceptibility of the Acinetobacter lwoffii isolate grown in blood culture
| Antibiotics | MIC (μg/ml) | Interpretation | Antibiotics | MIC (μg/ml) | Interpretation | |
| ABPC | ≦8 | NA | MEPM | ≦1 | S | |
| PIPC | ≦8 | S | AZT | 8 | NA | |
| CEZ | >16 | NA | CPZ/SBT | ≦16 | S | |
| CTM | >16 | NA | ABPC/SBT | ≦8 | S | |
| CTX | >2 | N/R | GM | ≦2 | S | |
| CAZ | ≦4 | S | TOB | ≦2 | S | |
| CTRX | >2 | N/R | AMK | ≦8 | S | |
| CFPM | 16 | I | MINO | ≦2 | S | |
| CZOP | ≦4 | S | CPFX | ≦0.25 | S | |
| CMZ | 16 | NA | LVFX | ≦0.5 | S | |
| CCL | ≦8 | NA | CL | ≦2 | S | |
| CFPN | >1 | NA | FOM | >16 | NA | |
| FMOX | 32 | NA | ST | ≦40 | S | |
| IPM | ≦1 | S |
(Abbreviations)
ABPC, ampicillin; AMK, amikacin; AZT, azidothymidine; CAZ, ceftazidime; CCL, cefaclor; CEZ, cefazolin; CFPN, cefcapene; CL, colistin; CPZ, chlorpromazine; CTM, ceftizoxime; CTRX, ceftriaxone; CTX, ceftriaxone; FMOX, flomoxef; FOM, fosfomycin; GM, gentamicin; I: intermediate, IPM, imipenem; LVFX, levofloxacin; MIC, minimal inhibitory concentration; MEPM, meropenem; MINO, minocycline; NA: not available, N/R: not reported; PIPC, piperacillin; S: susceptible; SBT, sulbactam; ST, streptomycin; TOB, tobramycin.